Showing results (601-610 of 861) with videos related to

Sort By:
Pageof 87
Lupus Science & Medicine|April 22, 2026
Elevated serum brain injury markers are associated with disease activity, pro-inflammatory cytokine levels and cognitive dysfunction in adolescents with childhood-onset SLEOscar Mwizerwa, Justine Ledochowski, Ganesh Ramanathan, et al.
Lupus Science & Medicine|April 21, 2026
Serum lipidomic and metabolomic signatures link epicardial adipose tissue to cardiovascular diseases in SLE: a post-hoc analysisLevi-Dan Azoulay, Fanny Urbain, Maharajah Ponnaiah, et al.
Lupus Science & Medicine|May 22, 2026
Antiphospholipid antibody associated retinal microvascular impairment: a case report and literature reviewErqian Wang, Jun Li, Lu Sun, et al.
Lupus Science & Medicine|March 1, 2017
Is frailty a relevant concept in SLE?Patricia P Katz, James Andrews, Jinoos Yazdany, et al.
Lupus Science & Medicine|July 1, 2026
Anti-endothelin receptor A autoantibodies associate with immunovascular risk and activate endothelial signalling in SLEMarice K McCrorey, Helen M Butler, Marie Elaine Zehntner, et al.
Lupus Science & Medicine|July 2, 2026
Remission and low disease activity state in childhood-onset systemic lupus erythematosus: differential impact on damage accrual in a Latin American cohort (GLADEL)R Ezequiel Borgia, Manuel F Ugarte-Gil, Deborah M Levy, et al.
Lupus Science & Medicine|July 2, 2026
Development and validation of a lectin-based assay for detection of IgG Fc glycosylation as a biomarker in lupus nephritisRohit Upadhyay, Juan Gao, Alexia M Michelle Orellana Enamorado, et al.
Lupus Science & Medicine|June 25, 2026
Development of a LASSO-based machine learning model for relapse prediction in lupus nephritisHao Liu, Yan Zheng, Jin Ding, et al.
Lupus Science & Medicine|August 3, 2026
Peripheral blood CD19+B cell proportion at baseline predicts early complete response to belimumab treatment in patients with refractory lupus nephritisXinxin Xie, Yan Zhou, Quangang Zhu, et al.
Lupus Science & Medicine|July 13, 2021
A multianalyte assay panel with cell-bound complement activation products demonstrates clinical utility in systemic lupus erythematosusRoberta Vezza Alexander, Daniel Scott Rey, John Conklin, et al.
Pageof 87